EUA
Biomeme SARS-CoV-2 Real-Time RT-PCR Test
FDA Emergency Use Authorization · Biomeme, Inc. · Mar 24, 2023
Key facts
| Product | Biomeme SARS-CoV-2 Real-Time RT-PCR Test |
|---|---|
| Company | Biomeme, Inc. |
| Product type | Real-time RT-PCR, Pooled Serial Screening - Swab, Pooled Serial Screening - Media, Multiple Targets |
| Date | Mar 24, 2023 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: